Propranolol for Treatment of Cocaine Addiction - 2
Information source: National Institute on Drug Abuse (NIDA)
ClinicalTrials.gov processed this data on August 23, 2015
Link to the current ClinicalTrials.gov record.
Condition(s) targeted: Cocaine-Related Disorders
Intervention: Propranolol (Drug)
Phase: Phase 2
Sponsored by: National Institute on Drug Abuse (NIDA)
Official(s) and/or principal investigator(s):
Kyle Kampman, M.D., Principal Investigator, Affiliation: University of Pennsylvania
The purpose of this study is to evaluate the safety and efficacy of propanolol in the early
treatment of cocaine dependence.
Official title: Propranolol for Treatment of Cocaine Addiction
Study design: Primary Purpose: Treatment
Mood and anxiety
Minimum age: 25 Years.
Maximum age: 49 Years.
Please contact site for information.
Locations and Contacts
University of Pennsylvania, Philadelphia, Pennsylvania 19104 6178, United States
Starting date: January 1987
Last updated: February 3, 2010